Regulatory Process for Animal Biotechnology Safeguards Environment

Dec 15 2011
FDA:  GE salmon will not have significant impact on the environment Washington, D.C. (December 15, 2011) – The Senate Commerce, Science, and Transportation Committee’s Subcommitteeon Oceans, Atmosphere, Fisheries, and Coast Guard held a hearing today to examine the environmental issues around genetically engineered (GE) fish.  

BIO Applauds Congress for Supporting Commercialization of Advanced Biofuels for Military Use

Dec 15 2011
Biotechnology companies researching and developing advanced biofuels can help diversify the military’s energy supply and advance U.S. national and energy security objectives.

BIO Asks Senate Committee to Target Tax Credits to Advanced Biofuel and Renewable Chemical Technologies That Will Create Jobs and Economic Growth

Dec 14 2011
BIO submitted written testimony to the Senate Finance Subcommittee on Energy, Natural Resources and Infrastructure. In the testimony, BIO noted that sustained, long-term tax policy is vital to emerging alternative energy technologies.

BIO Applauds House and Senate for Reaching Deal on SBIR Reauthorization

Dec 13 2011
Small Business Innovation Research (SBIR) grants provide critical funding for the development of innovative medical therapies for Cancer, Diabetes and HIV.

14th Annual BIO CEO & Investor Conference to Highlight Latest Investment and Deal Making Trends

Dec 6 2011
Washington, DC (December 6, 2011) – The Biotechnology Industry Organization (BIO) announces program topics planned for the BIO CEO & Investor Conference to be held February 13-14, 2012 at the Waldorf=Astoria in New York City, NY.

BIO Commends Advanced Biofuel Producers, Navy for Agreement to Fuel Demonstration of Great Green Fleet

Dec 5 2011
Achieving energy security is also a national security priority. Advanced biofuel companies have made significant investments and progress to meet the Navy’s goals for the Great Green Fleet.

BIO Announces Presenting Companies for 14th Annual BIO CEO & Investor Conference

Nov 22 2011
BIO CEO & Investor Conference will be held February 13 – 14 in New York City, NY 

Biotech Leader Provides Testimony on Bioethical Issues in International Clinical Trials

Nov 17 2011
A timely and consistent regulatory process will ultimately result in medical treatments and cures for some of the most devastating and life-threatening diseases... 

Wisconsin Bioscience Fund Makes Good Business Sense

Nov 16 2011
"The most important return on investment from this initiative would be the creation of additional high-skill, high-wage jobs and an opportunity to retain the best and brightest students from Wisconsin's world-class universities," says Bryan Renk, Executive Director of BioForward.

Registration for the 2012 BIO International Convention Now Available

Nov 16 2011
Global Event for Biotechnology to be Held June 18-21, 2012 in Boston